Home / News / Industry News / PFAS Chemical Disclosure Corresponding to AB1200 of the State of California, USA

PFAS Chemical Disclosure Corresponding to AB1200 of the State of California, USA

Update:06 Dec

Summary:Any of our products produced for the US market, without being claimed of “Free of PFAS”, includes be...

Any of our products produced for the US market, without being claimed of “Free of PFAS”, includes below PFAS chemicals, which are intentionally added for nonstick function purpose.
(1).1-Propene, 1,1,2,3,3,3-hexafluoro-, polymer with 1,1,2,2-tetrafluoroethene(CAS 25067-11-2)
(2). Polytetrafluoroethylene(CAS 9002-84-0)
The above two PFAS chemicals are included in the Calsafer Candidate Chemicals list, designated by the California Department of Toxic Substances Control, by refering the authoritative lists below, which might be updated by DTSC at any time. The most updated authoritative lists can be found via link: https://dtsc.ca.gov/scp/candidate-chemicals-list/

Cualquier producto que produzcamos para el mercado estadounidense (sin declarar "sin pfas") incluye los siguientes productos químicos pfas, que se agregan deliberadamente para funciones antiadherentes.
(1).1-Propene, 1,1,2,3,3,3-hexafluoro-, polymer with 1,1,2,2-tetrafluoroethene(CAS 25067-11-2)
(2). Polytetrafluoroethylene(CAS 9002-84-0) Los dos productos químicos PFAS mencionados se incluyen en la lista de productos químicos candidatos a calsafer designada por el Departamento de control de sustancias tóxicas de california, con referencia a la siguiente lista autorizada, y el dtsc se puede actualizar en cualquier momento. Se puede encontrar la última lista autorizada a través del enlace
https://dtsc.ca.gov/scp/candidate-chemicals-list/

EC EDs
EC Annex VI Resp. Sens. - Cat. 1
EC Annex VI CMRs - Cat. 1B
CECBP - Priority Chemicals
EC Annex VI CMRs - Cat. 1A
EC Annex VI CMRs - Cat. 1A; EC Annex VI CMRs - Cat. 1B; EC Annex VI Resp. Sens. - Cat. 1
Canada PBiTs
CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; Prop 65
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 2A; IRIS Neurotoxicants; OEHHA RELs
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; IRIS Carcinogens - Likely Carcin.; Prop 65
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); Prop 65
CA MCLs; CWA 303(d); IRIS Neurotoxicants
CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); Prop 65
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; OEHHA RELs; Prop 65
CA TACs; CDC 4th National Exposure Report; CWA 303(d); OEHHA RELs; WA PBTs
CA TACs; CDC 4th National Exposure Report; CWA 303(d); WA PBTs
CDC 4th National Exposure Report
OSPAR Priority Action Part A
CA MCLs; CDC 4th National Exposure Report; CWA 303(c); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; IRIS Carcinogens - Likely Carcin.; NTP 13th RoC - reasonable; Prop 65
IRIS Neurotoxicants
Canada PBiTs; U.S. EPA NWMP PBTs; WA PBTs
CA MCLs; CA TACs; CWA 303(c); CWA 303(d); OSPAR Priority Action Part A; U.S. EPA NWMP PBTs
CA NLs; IRIS Neurotoxicants
Canada PBiTs; CECBP - Priority Chemicals
CA MCLs; CA TACs; CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1A; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65
CWA 303(d)
CA MCLs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d)
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 1; Prop 65
IARC Carcinogens - 2B; Prop 65
EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; Prop 65
CA TACs; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65
CA TACs; IARC Carcinogens - 2B; OEHHA RELs
ATSDR Neurotoxicants
ATSDR Neurotoxicants; CA TACs; CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1A; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 1; IRIS Carcinogens - Carcin.; NTP 13th RoC - known; OEHHA RELs; Prop 65
EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; Prop 65
CDC 4th National Exposure Report; CWA 303(c)
CA MCLs; CA TACs; CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65
ATSDR Neurotoxicants; Prop 65
EC PBTs
CA TACs; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; NTP 13th RoC - reasonable; Prop 65
IARC Carcinogens - 1; NTP 13th RoC - reasonable; Prop 65
EC Annex VI CMRs - Cat. 1B; Prop 65
CA NLs; CA TACs; CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; IRIS Carcinogens - Likely Carcin.; IRIS Neurotoxicants; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65
IARC Carcinogens - 1; NTP 13th RoC - known; Prop 65
IARC Carcinogens - 2A; NTP 13th RoC - reasonable; Prop 65
NTP 13th RoC - reasonable; Prop 65
IARC Carcinogens - 2B
ATSDR Neurotoxicants; CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; NTP OHAT - Repr. or Dev. Toxicants; Prop 65
EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; NTP 13th RoC - reasonable; Prop 65
CDC 4th National Exposure Report; Prop 65
CECBP - Priority Chemicals; IARC Carcinogens - 2A; NTP 13th RoC - reasonable; Prop 65
Canada PBiTs; EC Annex VI CMRs - Cat. 1B; WA PBTs
EC Annex VI CMRs - Cat. 1B; WA PBTs EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65
CA TACs
CECBP - Priority Chemicals; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65
CA TACs; CDC 4th National Exposure Report; CWA 303(d); IARC Carcinogens - 1; OEHHA RELs; WA PBTs
CDC 4th National Exposure Report; WA PBTs
CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 1; NTP 13th RoC - known; OEHHA RELs; OSPAR Priority Action Part A; Prop 65; WA PBTs
EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65
EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A
CA MCLs
CA TACs; CDC 4th National Exposure Report; U.S. EPA NWMP PBTs
Canada PBiTs; OSPAR Priority Action Part A
CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; IRIS Carcinogens - B2
EC PBTs; OSPAR Priority Action Part A
Prop 65
EC Annex VI CMRs - Cat. 1B; NTP 13th RoC - reasonable; Prop 65
CA TACs; CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65
CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d)
CA MCLs; CA TACs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; IARC Carcinogens - 2B
CWA 303(c); CWA 303(d); IRIS Neurotoxicants
CA TACs; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; IRIS Neurotoxicants; Prop 65
ATSDR Neurotoxicants; CWA 303(d); EC Annex VI CMRs - Cat. 1B; IRIS Carcinogens - B2; Prop 65
CA NLs; Prop 65
CDC 4th National Exposure Report; CECBP - Priority Chemicals
CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; Prop 65
CDC 4th National Exposure Report; IARC Carcinogens - 2B; Prop 65
Canada PBiTs; EC Annex VI Resp. Sens. - Cat. 1
CA TACs; NTP 13th RoC - reasonable; Prop 65
CDC 4th National Exposure Report; IARC Carcinogens - 2A; NTP 13th RoC - reasonable; Prop 65
EC Annex VI CMRs - Cat. 1A; NTP OHAT - Repr. or Dev. Toxicants; Prop 65
OEHHA RELs
CWA 303(c); CWA 303(d)
IARC Carcinogens - 2A; Prop 65
ATSDR Neurotoxicants; CA TACs; CWA 303(c); CWA 303(d)
CA TACs; EC Annex VI Resp. Sens. - Cat. 1; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; OEHHA RELs
CA TACs; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65
ATSDR Neurotoxicants; CWA 303(c); CWA 303(d)
CA TACs; IRIS Neurotoxicants
CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1A; IARC Carcinogens - 1; NTP 13th RoC - known; Prop 65
CWA 303(c)
Prop 65; WA PBTs
CA TACs; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 1; NTP 13th RoC - reasonable; Prop 65
CA TACs; CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
CWA 303(c); CWA 303(d); U.S. EPA NWMP PBTs
EC Annex VI Resp. Sens. - Cat. 1; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; OEHHA RELs
CA TACs; EC Annex VI CMRs - Cat. 1B; Prop 65
CA TACs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d)
CDC 4th National Exposure Report; EC EDs; OSPAR Priority Action Part A
IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65; WA PBTs
CDC 4th National Exposure Report; CECBP - Priority Chemicals; IRIS Neurotoxicants
CA TACs; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; IRIS Carcinogens - B2; IRIS Neurotoxicants; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65 CA TACs; IARC Carcinogens - 2B; Prop 65 CDC 4th National Exposure Report; IRIS Neurotoxicants; Prop 65
CA TACs; OEHHA RELs
CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 2A; OEHHA RELs
ATSDR Neurotoxicants; CA TACs; CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; IRIS Carcinogens - Likely Carcin.; IRIS Neurotoxicants; NTP 13th RoC - reasonable; NTP OHAT - Repr. or Dev. Toxicants; Prop 65
CA TACs; IRIS Neurotoxicants; OEHHA RELs
ATSDR Neurotoxicants; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; IRIS Carcinogens - B1; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
IARC Carcinogens - 2A; NTP 13th RoC - reasonable
CA MCLs; CDC 4th National Exposure Report; CWA 303(d); Prop 65
CA MCLs; CDC 4th National Exposure Report
CWA 303(d); IRIS Neurotoxicants
ATSDR Neurotoxicants; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d); IARC Carcinogens - 2A; IRIS Carcinogens - B2; Prop 65; U.S. EPA TRI PBTs; WA PBTs EC Annex VI CMRs - Cat. 1A;
EC Annex VI CMRs - Cat. 1B
Canada PBiTs; CECBP - Priority Chemicals; EC PBTs; OSPAR Priority Action Part A; WA PBTs
Canada PBiTs; EC PBTs
ATSDR Neurotoxicants; CA TACs; CWA 303(c); CWA 303(d); IRIS Carcinogens - B2; OSPAR Priority Action Part A; Prop 65
IARC Carcinogens - 2A
ATSDR Neurotoxicants; CA MCLs; CWA 303(d)
CWA 303(d); OEHHA RELs
EC Annex VI CMRs - Cat. 1B; EC Annex VI Resp. Sens. - Cat. 1
EC Annex VI CMRs - Cat. 1B; EC PBTs
NTP 13th RoC - known; Prop 65
CA TACs; IARC Carcinogens - 2A; IRIS Carcinogens - B2; Prop 65
CWA 303(c); CWA 303(d); EC PBTs; U.S. EPA NWMP PBTs
CA MCLs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d)
IARC Carcinogens - 2B; IRIS Carcinogens - B2; Prop 65
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d); IARC Carcinogens - 1; IRIS Carcinogens - A; NTP 13th RoC - known; OEHHA RELs; Prop 65
EC Annex VI CMRs - Cat. 1A; IARC Carcinogens - 1
IARC Carcinogens - 1
CA MCLs; CWA 303(c); CWA 303(d); IARC Carcinogens - 1; IRIS Carcinogens - A; Prop 65
CA TACs; EC Annex VI CMRs - Cat. 1A; IARC Carcinogens - 1; NTP 13th RoC - known
EC Annex VI CMRs - Cat. 1B; IRIS Carcinogens - B2; Prop 65
CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c)
CDC 4th National Exposure Report; CECBP - Priority Chemicals; EC PBTs; IRIS Neurotoxicants; OSPAR Priority Action Part A; WA PBTs
CA MCLs; CWA 303(d)
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1A; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 1; IRIS Carcinogens - A; NTP 13th RoC - known; OEHHA RELs; Prop 65
Canada PBiTs; WA PBTs
ATSDR Neurotoxicants; CA TACs; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1A; IARC Carcinogens - 1; IRIS Carcinogens - A; IRIS Neurotoxicants; NTP 13th RoC - known; Prop 65
CWA 303(c); CWA 303(d); EC PBTs; U.S. EPA NWMP PBTs; U.S. EPA TRI PBTs; WA PBTs
CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; EC PBTs; IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65
CA MCLs; CA TACs; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; EC PBTs; IARC Carcinogens - 1; IRIS Carcinogens - Carcin.; IRIS Neurotoxicants; NTP 13th RoC - reasonable; Prop 65
CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65; WA PBTs
CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65; WA PBTs
CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; EC PBTs; IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65; WA PBTs CA TACs; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65
CA TACs; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; IRIS Carcinogens - B2; OEHHA RELs; Prop 65
CA MCLs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; OEHHA RELs; Prop 65
CA TACs; CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 1; IRIS Carcinogens - B1; NTP 13th RoC - known; OEHHA RELs; Prop 65
CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); OSPAR Priority Action Part A; Prop 65
CA TACs; EC Annex VI CMRs - Cat. 1B
CA TACs; CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1A; IARC Carcinogens - 1; NTP 13th RoC - known; Prop 65
CWA 303(c); CWA 303(d); Prop 65
CA TACs; CWA 303(c); CWA 303(d); IRIS Carcinogens - B2; Prop 65
CA TACs; EC Annex VI CMRs - Cat. 1A; IARC Carcinogens - 1; IRIS Carcinogens - A; NTP 13th RoC - known; Prop 65
CECBP - Priority Chemicals; EC PBTs
CDC 4th National Exposure Report; CECBP - Priority Chemicals; EC Annex VI CMRs - Cat. 1B; EC EDs; NTP OHAT - Repr. or Dev. Toxicants; Prop 65
CECBP - Priority Chemicals; EC EDs
CA NLs; CWA 303(d)
IRIS Carcinogens - B2; Prop 65
CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65
CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IRIS Carcinogens - B2; Prop 65
CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); EC Annex VI CMRs - Cat. 1B; NTP OHAT - Repr. or Dev. Toxicants; Prop 65
CDC 4th National Exposure Report; CECBP - Priority Chemicals; EC EDs
Canada PBiTs; EC Annex VI CMRs - Cat. 1B; Prop 65
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d); IARC Carcinogens - 1; IRIS Carcinogens - B1; OEHHA RELs; OSPAR Priority Action Part A; Prop 65; U.S. EPA NWMP PBTs; WA PBTs
CA TACs; CWA 303(d); IARC Carcinogens - 1; OEHHA RELs; OSPAR Priority Action Part A
CA TACs; NTP 13th RoC - known; OEHHA RELs; Prop 65
CA TACs; Prop 65
CA TACs; CWA 303(d); Prop 65
CA MCLs; CDC 4th National Exposure Report; CWA 303(d); IRIS Neurotoxicants
ATSDR Neurotoxicants; CA NLs; CA TACs; CDC 4th National Exposure Report; IRIS Neurotoxicants; OEHHA RELs; Prop 65
ATSDR Neurotoxicants; EC Annex VI CMRs - Cat. 1A; OEHHA RELs; Prop 65
CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; IRIS Carcinogens - Likely Carcin.; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
ATSDR Neurotoxicants; CA TACs
CA TACs; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; Prop 65
IARC Carcinogens - 2A; IRIS Neurotoxicants; Prop 65
CA NLs
ATSDR Neurotoxicants; CA MCLs; CA TACs; Canada PBiTs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; Prop 65; U.S. EPA TRI PBTs; WA PBTs IRIS Carcinogens - B2
IARC Carcinogens - 2B;IRIS Carcinogens - Likely Carcin.; NTP 13th RoC - reasonable; Prop 65; WA PBTs
CECBP - Priority Chemicals; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65
CA TACs; CDC 4th National Exposure Report; CWA 303(c); OEHHA RELs; U.S. EPA TRI PBTs
IRIS Neurotoxicants; OEHHA RELs
IARC Carcinogens - 1; Prop 65
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); OEHHA RELs
CA TACs; IRIS Neurotoxicants; Prop 65
CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); OEHHA RELs; Prop 65
ATSDR Neurotoxicants; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; IRIS Carcinogens - Likely Carcin.; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
CA TACs; EC Annex VI CMRs - Cat. 1A; IARC Carcinogens - 1; IRIS Carcinogens - A; Prop 65
CA TACs; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; IRIS Carcinogens - Likely Carcin.; IRIS Neurotoxicants; NTP 13th RoC - reasonable; Prop 65 ATSDR Neurotoxicants; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(d); Prop 65
CA TACs; CWA 303(c); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 1; IRIS Carcinogens - A; NTP 13th RoC - known; OEHHA RELs; Prop 65
CA TACs; CDC 4th National Exposure Report; CWA 303(d); OEHHA RELs
EC Annex VI CMRs - Cat. 1A; EC Annex VI CMRs - Cat. 1B; EC Annex VI Resp. Sens. - Cat. 1; OEHHA RELs
CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; EC PBTs; IARC Carcinogens - 2B; IRIS Carcinogens - B2; Prop 65; WA PBTs
CA MCLs; CDC 4th National Exposure Report; CWA 303(d)
CA TACs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; EC Annex VI CMRs - Cat. 1B; EC Annex VI Resp. Sens. - Cat. 1; IARC Carcinogens - 2A; Prop 65
EC Annex VI CMRs - Cat. 1B; EC Annex VI Resp. Sens. - Cat. 1; NTP 13th RoC - reasonable; Prop 65
IARC Carcinogens - 2B; NTP 13th RoC - reasonable
CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); OEHHA RELs
CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(d)
EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; IRIS Carcinogens - B1; Prop 65
ATSDR Neurotoxicants; CA TACs; OEHHA RELs
CDC 4th National Exposure Report; IARC Carcinogens - 2B
CA NLs; CA TACs; CDC 4th National Exposure Report; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d)
CWA 303(d); IARC Carcinogens - 2B; Prop 65
Canada PBiTs; Prop 65
ATSDR Neurotoxicants; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d); EC PBTs; IARC Carcinogens - 2A; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65; WA PBTs
ATSDR Neurotoxicants; CECBP - Priority Chemicals
Canada PBiTs; CECBP - Priority Chemicals; EC PBTs
ATSDR Neurotoxicants; CDC 4th National Exposure Report
CA MCLs; CA TACs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; EC EDs; IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; NTP OHAT - Repr. or Dev. Toxicants; OSPAR Priority Action Part A; Prop 65
CDC 4th National Exposure Report; CECBP - Priority Chemicals; NTP OHAT - Repr. or Dev. Toxicants; Prop 65
CECBP - Priority Chemicals; EC Annex VI CMRs - Cat. 1B; NTP OHAT - Repr. or Dev. Toxicants; Prop 65
CDC 4th National Exposure Report;CECBP - Priority Chemicals; CWA 303(c); NTP OHAT - Repr. or Dev. Toxicants
CECBP - Priority Chemicals; EC Annex VI CMRs - Cat. 1B
EC Annex VI CMRs - Cat. 1A; EC Annex VI Resp. Sens. - Cat. 1
ATSDR Neurotoxicants; CA NLs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(d);
IARC Carcinogens - 2A IARC Carcinogens - 2A; NTP 13th RoC - reasonable; Prop 65; WA PBTs
NTP 13th RoC - reasonable; Prop 65; WA PBTs
CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65; WA PBTs
EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65; WA PBTs
CA TACs; U.S. EPA NWMP PBTs
CDC 4th National Exposure Report; CWA 303(c); CWA 303(d)
CA TACs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; NTP OHAT - Repr. or Dev. Toxicants; Prop 65
IARC Carcinogens - 2B; IRIS Carcinogens - Likely Carcin.; IRIS Neurotoxicants; Prop 65
ATSDR Neurotoxicants; CA TACs; CECBP - Priority Chemicals; CWA 303(d); IARC Carcinogens - 2B; IRIS Carcinogens - B2; IRIS Neurotoxicants; Prop 65
CDC 4th National Exposure Report; CECBP - Priority Chemicals; EC Annex VI CMRs - Cat. 1B; EC EDs
ATSDR Neurotoxicants; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 2A; IRIS Carcinogens - B2; Prop 65; WA PBTs
CECBP - Priority Chemicals; IARC Carcinogens - 1; IRIS Carcinogens - Likely Carcin.; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
CA TACs; IARC Carcinogens - 2B; OEHHA RELs; Prop 65
CDC 4th National Exposure Report; CECBP - Priority Chemicals; EC Annex VI CMRs - Cat. 1B
CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(d); IRIS Neurotoxicants
CDC 4th National Exposure Report; CECBP - Priority Chemicals; IARC Carcinogens - 2B; Prop 65
CA TACs; CWA 303(c); CWA 303(d)
CA MCLs; CWA 303(d); EC Annex VI CMRs - Cat. 1B; Prop 65
CA TACs; CDC 4th National Exposure Report; CWA 303(d); U.S. EPA NWMP PBTs
Canada PBiTs; EC Annex VI CMRs - Cat. 1B
ATSDR Neurotoxicants; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d); IRIS Neurotoxicants
CWA 303(d); Prop 65
CA TACs; IRIS Carcinogens - A; NTP 13th RoC - known; Prop 65
ATSDR Neurotoxicants; CWA 303(d); EC PBTs; OSPAR Priority Action Part A
ATSDR Neurotoxicants; CA MCLs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IRIS Neurotoxicants; Prop 65; WA PBTs
CA TACs; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
EC Annex VI CMRs - Cat. 1A; Prop 65
IARC Carcinogens - 1; NTP 13th RoC - known
ATSDR Neurotoxicants; CECBP - Priority Chemicals; IRIS Neurotoxicants
CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; IRIS Carcinogens - Likely Carcin.; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
CA NLs; CA TACs; NTP OHAT - Repr. or Dev. Toxicants; OEHHA RELs; Prop 65
CA TACs; EC Annex VI CMRs - Cat. 1B; OEHHA RELs; Prop 65
EC Annex VI CMRs - Cat. 1B; OEHHA RELs; Prop 65
ATSDR Neurotoxicants; CA TACs; CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 1; IRIS Carcinogens - Carcin.; NTP 13th RoC - known; OEHHA RELs; Prop 65
CA TACs; CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1B; NTP 13th RoC - reasonable; Prop 65
CECBP - Priority Chemicals; CWA 303(d)
NTP 13th RoC - reasonable
CWA 303(c); CWA 303(d); EC PBTs; WA PBTs
CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); U.S. EPA NWMP PBTs
CA MCLs; CWA 303(d); OEHHA RELs
CA NLs; CA TACs; CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 1; IRIS Carcinogens - B1; NTP 13th RoC - known; OEHHA RELs; Prop 65
Canada PBiTs; CWA 303(d); EC Annex VI CMRs - Cat. 1B
ATSDR Neurotoxicants; CWA 303(d)
CDC 4th National Exposure Report; CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65
CA MCLs; CA TACs; Canada PBiTs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); EC PBTs; IARC Carcinogens - 1; NTP 13th RoC - reasonable; OSPAR Priority Action Part A; Prop 65; U.S. EPA NWMP PBTs
ATSDR Neurotoxicants; CWA 303(d); EC Annex VI CMRs - Cat. 1B
CDC 4th National Exposure Report; NTP OHAT - Repr. or Dev. Toxicants
EC Annex VI Resp. Sens. - Cat. 1; OEHHA RELs
CA MCLs; CWA 303(d); IARC Carcinogens - 2A; Prop 65
CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; IRIS Carcinogens - B2; Prop 65; U.S. EPA NWMP PBTs; U.S. EPA TRI PBTs; WA PBTs
CA MCLs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IRIS Carcinogens - B2; Prop 65; U.S. EPA NWMP PBTs; WA PBTs
WA PBTs
EC PBTs; U.S. EPA TRI PBTs; WA PBTs
CA MCLs; CA TACs; Canada PBiTs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; EC PBTs; IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65; U.S. EPA NWMP PBTs; U.S. EPA TRI PBTs; WA PBTs
CA TACs; Canada PBiTs; CWA 303(c); CWA 303(d); Prop 65; U.S. EPA NWMP PBTs; WA PBTs
CA MCLs; CA TACs; CWA 303(c); CWA 303(d)
CA TACs; CDC 4th National Exposure Report; Prop 65
CDC 4th National Exposure Report; IRIS Carcinogens - B2
ATSDR Neurotoxicants; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; IRIS Carcinogens - Likely Carcin.; IRIS Neurotoxicants; NTP 13th RoC - reasonable; Prop 65; U.S. EPA NWMP PBTs
CA TACs; EC Annex VI Resp. Sens. - Cat. 1; IRIS Neurotoxicants; OEHHA RELs
ATSDR Neurotoxicants; CA NLs
ATSDR Neurotoxicants; CWA 303(d); IRIS Neurotoxicants; OEHHA RELs
CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65; WA PBTs
ATSDR Neurotoxicants; IARC Carcinogens - 1; NTP 13th RoC - known
U.S. EPA TRI PBTs
CA TACs; CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; OEHHA RELs
ATSDR Neurotoxicants; CA TACs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; OSPAR Priority Action Part A; Prop 65; U.S. EPA NWMP PBTs; U.S. EPA TRI PBTs; WA PBTs
CA TACs; U.S. EPA TRI PBTs
ATSDR Neurotoxicants; EC Annex VI CMRs - Cat. 1A; IARC Carcinogens - 2A; IRIS Carcinogens - B2; Prop 65
IRIS Carcinogens - Carcin.
CA TACs; EC Annex VI Resp. Sens. - Cat. 1; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
CA TACs; CDC 4th National Exposure Report
ATSDR Neurotoxicants; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(d); IARC Carcinogens - 2A; IRIS Neurotoxicants; Prop 65
CA TACs; EC Annex VI Resp. Sens. - Cat. 1; OEHHA RELs
ATSDR Neurotoxicants; CA NLs; CA TACs; CDC 4th National Exposure Report; CWA 303(d); IRIS Neurotoxicants; OEHHA RELs
CECBP - Priority Chemicals; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; IRIS Neurotoxicants; OEHHA RELs; OSPAR Priority Action Part A; U.S. EPA NWMP PBTs; U.S. EPA TRI PBTs
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); OEHHA RELs; OSPAR Priority Action Part A; Prop 65; U.S. EPA TRI PBTs
ATSDR Neurotoxicants; IRIS Neurotoxicants; Prop 65 CA TACs; IRIS Neurotoxicants; NTP OHAT - Repr. or Dev. Toxicants; OEHHA RELs; Prop 65 CA MCLs; CA TACs; OSPAR Priority Action Part A; U.S. EPA NWMP PBTs; U.S. EPA TRI PBTs
ATSDR Neurotoxicants; CA TACs; CWA 303(c); IRIS Neurotoxicants; OEHHA RELs; Prop 65
ATSDR Neurotoxicants; CA TACs; CWA 303(c); CWA 303(d); IRIS Neurotoxicants; Prop 65
CA NLs; CA TACs; IARC Carcinogens - 2B; Prop 65
CA TACs; EC Annex VI Resp. Sens. - Cat. 1; OEHHA RELs; Prop 65
IRIS Neurotoxicants; WA PBTs
CDC 4th National Exposure Report; CWA 303(c); IARC Carcinogens - 2B; Prop 65; WA PBTs
ATSDR Neurotoxicants; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(d); IRIS Neurotoxicants
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; OEHHA RELs
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 2A; IRIS Carcinogens - Likely Carcin.; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
CA TACs; EC Annex VI Resp. Sens. - Cat. 1; Hazard Traits identified by DTSC; IRIS Neurotoxicants; OEHHA RELs
EC Annex VI Resp. Sens. - Cat. 1; Hazard Traits identified by DTSC
CWA 303(d); IARC Carcinogens - 1; NTP 13th RoC - known
ATSDR Neurotoxicants; CDC 4th National Exposure Report; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65; WA PBTs
CA MCLs; CWA 303(d); Prop 65
CA TACs; CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; OEHHA RELs; Prop 65
ATSDR Neurotoxicants; CA TACs; CWA 303(d); IRIS Neurotoxicants; OEHHA RELs; Prop 65
IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65
CA TACs; IARC Carcinogens - 2A; NTP 13th RoC - reasonable; Prop 65
CA NLs; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65
CA NLs; CDC 4th National Exposure Report; IARC Carcinogens - 2A; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65
CA NLs; CA TACs; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65 CWA 303(c); CWA 303(d); IRIS Carcinogens - B2; Prop 65
CDC 4th National Exposure Report; IARC Carcinogens - 2B; IRIS Carcinogens - B2; Prop 65
CA TACs; CDC 4th National Exposure Report; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65
CDC 4th National Exposure Report; IARC Carcinogens - 1; NTP 13th RoC - reasonable; Prop 65
CDC 4th National Exposure Report; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65
CDC 4th National Exposure Report; IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65
CECBP - Priority Chemicals; CWA 303(d); IRIS Neurotoxicants
ATSDR Neurotoxicants; CA NLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; IRIS Neurotoxicants; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65; U.S. EPA NWMP PBTs
EC Annex VI CMRs - Cat. 1A; EC Annex VI CMRs - Cat. 1B; EC Annex VI Resp. Sens. - Cat. 1; Prop 65
CA TACs; CWA 303(c); CWA 303(d); IARC Carcinogens - 1; NTP 13th RoC - known; OEHHA RELs; Prop 65
EC Annex VI CMRs - Cat. 1A; OEHHA RELs; Prop 65
IRIS Carcinogens - A
CA MCLs; CA TACs; CWA 303(c); IARC Carcinogens - 2B; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
CDC 4th National Exposure Report; CECBP - Priority Chemicals; Prop 65
CA MCLs; CWA 303(d); IARC Carcinogens - 2A
ATSDR Neurotoxicants; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; IRIS Carcinogens - Likely Carcin.; IRIS Neurotoxicants; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
EC Annex VI CMRs - Cat. 1B; EC PBTs; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65
EC EDs; OSPAR Priority Action Part A
CA TACs; CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2A; NTP 13th RoC - reasonable; Prop 65
CA TACs; CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 1; NTP 13th RoC - known; Prop 65
CWA 303(c); OSPAR Priority Action Part A; Prop 65
CECBP - Priority Chemicals; Prop 65
ATSDR Neurotoxicants; CWA 303(c); CWA 303(d); IRIS Carcinogens - B2; Prop 65
ATSDR Neurotoxicants; CA TACs; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d); IRIS Carcinogens - B2; Prop 65
EC EDs; EC PBTs
CA MCLs; CA TACs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
CA TACs; IARC Carcinogens - 2B; NTP 13th RoC - reasonable; Prop 65
ATSDR Neurotoxicants; CA TACs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(d); IARC Carcinogens - 2B; Prop 65
CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(d); OEHHA RELs; WA PBTs
CDC 4th National Exposure Report; CWA 303(d); OEHHA RELs; WA PBTs
CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(d); OEHHA RELs
CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(d); IARC Carcinogens - 1; OEHHA RELs
CDC 4th National Exposure Report; CWA 303(d); OEHHA RELs
CWA 303(c); OEHHA RELs
CWA 303(d); U.S. EPA NWMP PBTs; U.S. EPA TRI PBTs
Canada PBiTs; U.S. EPA NWMP PBTs; U.S. EPA TRI PBTs; WA PBTs
CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 1; IRIS Carcinogens - Likely Carcin.; NTP 13th RoC - reasonable; OSPAR Priority Action Part A; Prop 65; U.S. EPA NWMP PBTs
CA MCLs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(d)
CA NLs; CDC 4th National Exposure Report; CECBP - Priority Chemicals
CDC 4th National Exposure Report; CECBP - Priority Chemicals; EC Annex VI CMRs - Cat. 1B; EC PBTs
CDC 4th National Exposure Report; CECBP - Priority Chemicals; EC PBTs
CA NLs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; EC Annex VI CMRs - Cat. 1B; OSPAR Priority Action Part A; Prop 65; WA PBTs
CA NLs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; EC Annex VI CMRs - Cat. 1B; EC PBTs; IARC Carcinogens - 2B; Prop 65
ATSDR Neurotoxicants; Canada PBiTs; EC Annex VI CMRs - Cat. 1B
CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); EC PBTs; U.S. EPA NWMP PBTs
CA TACs; CWA 303(c); CWA 303(d); OEHHA RELs
EC Annex VI CMRs - Cat. 1B; EC EDs
CECBP - Priority Chemicals; IRIS Neurotoxicants
CA TACs; CWA 303(d)
EC Annex VI CMRs - Cat. 1A; EC Annex VI CMRs - Cat. 1B; EC PBTs; IARC Carcinogens - 1
NTP 13th RoC - known
ATSDR Neurotoxicants; CA MCLs; CA TACs; Canada PBiTs; CWA 303(c); CWA 303(d); IARC Carcinogens - 1; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; OEHHA RELs; OSPAR Priority Action Part A; Prop 65; U.S. EPA NWMP PBTs; U.S. EPA TRI PBTs
CA TACs; OSPAR Priority Action Part A; Prop 65
CWA 303(d); OSPAR Priority Action Part A; U.S. EPA NWMP PBTs; U.S. EPA TRI PBTs
CA TACs; CDC 4th National Exposure Report; IRIS Neurotoxicants
CA TACs; CDC 4th National Exposure Report; IRIS Neurotoxicants; Prop 65
CA TACs; CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
ATSDR Neurotoxicants; IARC Carcinogens - 2B; Prop 65
CA TACs; EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; IRIS Carcinogens - B2; Prop 65
ATSDR Neurotoxicants; CA NLs; IRIS Neurotoxicants
EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable
CECBP - Priority Chemicals; CWA 303(d); Prop 65
CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IRIS Neurotoxicants; OEHHA RELs
IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65
NTP 13th RoC - known; OEHHA RELs; Prop 65
EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 2B; NTP 13th RoC - reasonable
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(d); IARC Carcinogens - 2A; IRIS Neurotoxicants; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
OEHHA RELs; Prop 65
IARC Carcinogens - 1; NTP 13th RoC - known; OEHHA RELs; Prop 65
EC Annex VI CMRs - Cat. 1A; IARC Carcinogens - 1; NTP 13th RoC - known
CECBP - Priority Chemicals; IARC Carcinogens - 2A; OSPAR Priority Action Part A; Prop 65; U.S. EPA TRI PBTs; WA PBTs
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IARC Carcinogens - 2A; IRIS Carcinogens - Likely Carcin.; IRIS Neurotoxicants; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
CECBP - Priority Chemicals; EC Annex VI Resp. Sens. - Cat. 1
CDC 4th National Exposure Report; CWA 303(d); IARC Carcinogens - 2B; IRIS Neurotoxicants; Prop 65
ATSDR Neurotoxicants; CA MCLs; CDC 4th National Exposure Report; CECBP - Priority Chemicals; CWA 303(c); CWA 303(d)
CDC 4th National Exposure Report; EC Annex VI CMRs - Cat. 1B
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); IRIS Neurotoxicants; OEHHA RELs; Prop 65
CA MCLs; CA TACs; CWA 303(c); CWA 303(d); IARC Carcinogens - 2B; IRIS Carcinogens - B2; NTP 13th RoC - reasonable; Prop 65; U.S. EPA TRI PBTs; WA PBTs CWA 303(d); OSPAR Priority Action Part A
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1B; IARC Carcinogens - 1; IRIS Carcinogens - Carcin.; NTP 13th RoC - reasonable; OEHHA RELs; Prop 65
CA TACs; Canada PBiTs; CWA 303(d); OSPAR Priority Action Part A; U.S. EPA NWMP PBTs; U.S. EPA TRI PBTs
EC Annex VI CMRs - Cat. 1A; IRIS Carcinogens - A; Prop 65
ATSDR Neurotoxicants; CDC 4th National Exposure Report; CECBP - Priority Chemicals; Hazard Traits identified by DTSC; Prop 65
ATSDR Neurotoxicants; CDC 4th National Exposure Report; CECBP - Priority Chemicals ATSDR Neurotoxicants; CDC 4th National Exposure Report; CECBP - Priority Chemicals; EC Annex VI CMRs - Cat. 1B; Hazard Traits identified by DTSC; Prop 65
IARC Carcinogens - 2B; OEHHA RELs; Prop 65
CA TACs; IARC Carcinogens - 2B; IRIS Neurotoxicants; OEHHA RELs
CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(c); CWA 303(d); EC Annex VI CMRs - Cat. 1A; IARC Carcinogens - 1; IRIS Carcinogens - A; NTP 13th RoC - known; OEHHA RELs; Prop 65
ATSDR Neurotoxicants; CA MCLs; CA TACs; CDC 4th National Exposure Report; CWA 303(d); IRIS Neurotoxicants; OEHHA RELs

PREV：La Divulgación Química del PFAS Corresponde al AB1200 en California, USA
NEXT：No next article

ABOUT US

Ningbo Taioor Cookware Co., Ltd. located in Chongshou Town Industrial Zone, Cixi City. Founded in 2003, is a professional production of series aluminum non-stick Cookware business, 100% products are exported, mainly sold to Europe, America, Southeast Asia, Australia, the Middle East.

READ MORE

quick links

PRODUCT

Contact US

ADD：Chongshou Industry Park, Cixi City, Zhejiang China.
TEL：0574-23702136
FAX：0574-23702123
E-Mail：[email protected] / [email protected]